schliessen

Filtern

 

Bibliotheken

Remission of collagen-induced arthritis through combination therapy of microfracture and transplantation of thermogel-encapsulated bone marrow mesenchymal stem cells

The persistent inflammation of rheumatoid arthritis (RA) always leads to partial synovial hyperplasia and the destruction of articular cartilage. Bone marrow mesenchymal stem cells (BMMSCs) have been proven to possess immunosuppressive effects, and widely explored in the treatment of autoimmune dise... Full description

Journal Title: PLoS ONE 01 January 2015, Vol.10(3), p.e0120596
Main Author: He Liu
Other Authors: Jianxun Ding , Jincheng Wang , Yinan Wang , Modi Yang , Yanbo Zhang , Fei Chang , Xuesi Chen
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0120596
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: doaj_soai_doaj_org_article_a401f07044594b0689b023abd02383d1
title: Remission of collagen-induced arthritis through combination therapy of microfracture and transplantation of thermogel-encapsulated bone marrow mesenchymal stem cells
format: Article
creator:
  • He Liu
  • Jianxun Ding
  • Jincheng Wang
  • Yinan Wang
  • Modi Yang
  • Yanbo Zhang
  • Fei Chang
  • Xuesi Chen
subjects:
  • Sciences (General)
ispartof: PLoS ONE, 01 January 2015, Vol.10(3), p.e0120596
description: The persistent inflammation of rheumatoid arthritis (RA) always leads to partial synovial hyperplasia and the destruction of articular cartilage. Bone marrow mesenchymal stem cells (BMMSCs) have been proven to possess immunosuppressive effects, and widely explored in the treatment of autoimmune diseases. However, poor inhibitory effect on local inflammatory state and limited capacity of preventing destruction of articular cartilage by systemic BMMSCs transplantation were observed. Herein, toward the classical type II collagen-induced arthritis in rats, the combination treatment of microfracture and in situ transplantation of thermogel-encapsulated BMMSCs was verified to obviously down-regulate the ratio of CD4+ to CD8+ T lymphocytes in peripheral blood. In addition, it resulted in the decreased levels of inflammatory cytokines, such as interleukin-1β, tumor necrosis factor-α and anti-collagen type II antibody, in the serum. Simultaneously, the combination therapy also could inhibit the proliferation of antigen specific lymphocytes and local joint inflammatory condition, and prevent the articular cartilage damage. The results indicated that the treatment programs could effectively stimulate the endogenous and exogenous BMMSCs to exhibit the immunosuppression and cartilage protection capability. This study provided a new therapeutic strategy for autoimmune inflammatory diseases, such as RA.
language: eng
source:
identifier: E-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0120596
fulltext: fulltext_linktorsrc
issn:
  • 1932-6203
  • 19326203
url: Link


@attributes
ID708008531
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordidoai_doaj_org_article_a401f07044594b0689b023abd02383d1
sourceiddoaj_s
recordidTN_doaj_soai_doaj_org_article_a401f07044594b0689b023abd02383d1
sourcesystemOther
dbidDOA
pqid1663912158
galeid425390953
display
typearticle
titleRemission of collagen-induced arthritis through combination therapy of microfracture and transplantation of thermogel-encapsulated bone marrow mesenchymal stem cells
creatorHe Liu ; Jianxun Ding ; Jincheng Wang ; Yinan Wang ; Modi Yang ; Yanbo Zhang ; Fei Chang ; Xuesi Chen
ispartofPLoS ONE, 01 January 2015, Vol.10(3), p.e0120596
identifierE-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0120596
subjectSciences (General)
descriptionThe persistent inflammation of rheumatoid arthritis (RA) always leads to partial synovial hyperplasia and the destruction of articular cartilage. Bone marrow mesenchymal stem cells (BMMSCs) have been proven to possess immunosuppressive effects, and widely explored in the treatment of autoimmune diseases. However, poor inhibitory effect on local inflammatory state and limited capacity of preventing destruction of articular cartilage by systemic BMMSCs transplantation were observed. Herein, toward the classical type II collagen-induced arthritis in rats, the combination treatment of microfracture and in situ transplantation of thermogel-encapsulated BMMSCs was verified to obviously down-regulate the ratio of CD4+ to CD8+ T lymphocytes in peripheral blood. In addition, it resulted in the decreased levels of inflammatory cytokines, such as interleukin-1β, tumor necrosis factor-α and anti-collagen type II antibody, in the serum. Simultaneously, the combination therapy also could inhibit the proliferation of antigen specific lymphocytes and local joint inflammatory condition, and prevent the articular cartilage damage. The results indicated that the treatment programs could effectively stimulate the endogenous and exogenous BMMSCs to exhibit the immunosuppression and cartilage protection capability. This study provided a new therapeutic strategy for autoimmune inflammatory diseases, such as RA.
languageeng
oafree_for_read
source
version9
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
linktorsrc$$Uhttps://doaj.org/article/a401f07044594b0689b023abd02383d1$$EView_full_text_in_DOAJ
search
creatorcontrib
0He Liu
1Jianxun Ding
2Jincheng Wang
3Yinan Wang
4Modi Yang
5Yanbo Zhang
6Fei Chang
7Xuesi Chen
titleRemission of collagen-induced arthritis through combination therapy of microfracture and transplantation of thermogel-encapsulated bone marrow mesenchymal stem cells
description

The persistent inflammation of rheumatoid arthritis (RA) always leads to partial synovial hyperplasia and the destruction of articular cartilage. Bone marrow mesenchymal stem cells (BMMSCs) have been proven to possess immunosuppressive effects, and widely explored in the treatment of autoimmune diseases. However, poor inhibitory effect on local inflammatory state and limited capacity of preventing destruction of articular cartilage by systemic BMMSCs transplantation were observed. Herein, toward the classical type II collagen-induced arthritis in rats, the combination treatment of microfracture and in situ transplantation of thermogel-encapsulated BMMSCs was verified to obviously down-regulate the ratio of CD4+ to CD8+ T lymphocytes in peripheral blood. In addition, it resulted in the decreased levels of inflammatory cytokines, such as interleukin-1β, tumor necrosis factor-α and anti-collagen type II antibody, in the serum. Simultaneously, the combination therapy also could inhibit the proliferation of antigen specific lymphocytes and local joint inflammatory condition, and prevent the articular cartilage damage. The results indicated that the treatment programs could effectively stimulate the endogenous and exogenous BMMSCs to exhibit the immunosuppression and cartilage protection capability. This study provided a new therapeutic strategy for autoimmune inflammatory diseases, such as RA.

subjectSciences (General)
general
0English
1Public Library of Science (PLoS)
210.1371/journal.pone.0120596
3Directory of Open Access Journals (DOAJ)
sourceiddoaj_s
recordiddoaj_soai_doaj_org_article_a401f07044594b0689b023abd02383d1
issn
01932-6203
119326203
rsrctypearticle
creationdate2015
addtitlePLoS ONE
searchscope
0doaj_full
1doaj1
scope
0doaj_full
1doaj1
lsr45$$EView_full_text_in_DOAJ
tmp01Directory of Open Access Journals (DOAJ)
tmp02DOA
startdate20150101
enddate20150101
lsr40PLoS ONE, 01 January 2015, Vol.10 (3), p.e0120596
doi10.1371/journal.pone.0120596
citationpf e0120596 vol 10 issue 3
lsr30VSR-Enriched:[pqid, pages, galeid]
sort
titleRemission of collagen-induced arthritis through combination therapy of microfracture and transplantation of thermogel-encapsulated bone marrow mesenchymal stem cells
authorHe Liu ; Jianxun Ding ; Jincheng Wang ; Yinan Wang ; Modi Yang ; Yanbo Zhang ; Fei Chang ; Xuesi Chen
creationdate20150101
lso0120150101
facets
frbrgroupid3580730362153842327
frbrtype5
newrecords20190714
languageeng
topicSciences (General)
collectionDirectory of Open Access Journals (DOAJ)
prefilterarticles
rsrctypearticles
creatorcontrib
0He Liu
1Jianxun Ding
2Jincheng Wang
3Yinan Wang
4Modi Yang
5Yanbo Zhang
6Fei Chang
7Xuesi Chen
jtitlePLoS ONE
creationdate2015
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext_linktorsrc
addata
au
0He Liu
1Jianxun Ding
2Jincheng Wang
3Yinan Wang
4Modi Yang
5Yanbo Zhang
6Fei Chang
7Xuesi Chen
atitleRemission of collagen-induced arthritis through combination therapy of microfracture and transplantation of thermogel-encapsulated bone marrow mesenchymal stem cells
jtitlePLoS ONE
risdate20150101
volume10
issue3
spagee0120596
eissn1932-6203
formatjournal
genrearticle
ristypeJOUR
abstract

The persistent inflammation of rheumatoid arthritis (RA) always leads to partial synovial hyperplasia and the destruction of articular cartilage. Bone marrow mesenchymal stem cells (BMMSCs) have been proven to possess immunosuppressive effects, and widely explored in the treatment of autoimmune diseases. However, poor inhibitory effect on local inflammatory state and limited capacity of preventing destruction of articular cartilage by systemic BMMSCs transplantation were observed. Herein, toward the classical type II collagen-induced arthritis in rats, the combination treatment of microfracture and in situ transplantation of thermogel-encapsulated BMMSCs was verified to obviously down-regulate the ratio of CD4+ to CD8+ T lymphocytes in peripheral blood. In addition, it resulted in the decreased levels of inflammatory cytokines, such as interleukin-1β, tumor necrosis factor-α and anti-collagen type II antibody, in the serum. Simultaneously, the combination therapy also could inhibit the proliferation of antigen specific lymphocytes and local joint inflammatory condition, and prevent the articular cartilage damage. The results indicated that the treatment programs could effectively stimulate the endogenous and exogenous BMMSCs to exhibit the immunosuppression and cartilage protection capability. This study provided a new therapeutic strategy for autoimmune inflammatory diseases, such as RA.

pubPublic Library of Science (PLoS)
doi10.1371/journal.pone.0120596
urlhttps://doaj.org/article/a401f07044594b0689b023abd02383d1
lad01PLoS ONE
oafree_for_read
pagese0120596
date2015-01-01